Irinotecan-Teva liquid 40 mg/2 ml
Irinotecan-Teva liquid 40 mg/2 ml is a medicine authorised by Swissmedic under authorisation number 59217. The authorisation holder is Teva Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 06 May 2009 and the authorisation is valid without a time limit. ATC code L01CE02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 59217 |
|---|---|
| Name | Irinotecan-Teva liquid 40 mg/2 ml |
| Full name | Irinotecan-Teva liquid 40 mg/2 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Teva Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01CE02 |
| First authorisation | 06 May 2009 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Irinotecan-Teva liquid 40 mg/2 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 06 May 2009 |
| 2 | Irinotecan-Teva liquid 100 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 06 May 2009 |
| 3 | Irinotecan-Teva liquid 500 mg/25 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 21 May 2010 |
| 4 | Irinotecan-Teva liquid 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 26 July 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 5 | 1 | Durchstechflasche(n) | L01CE02 | 07.16.1. | A |
| 6 | 1 | Durchstechflasche(n) | L01CE02 | 07.16.1. | A |
| 8 | 1 | Durchstechflasche(n) | L01CE02 | 07.16.1. | A |
| 7 | 1 | Durchstechflasche(n) | L01CE02 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Irinotecan-Teva liquid 40 mg/2 ml authorised in Switzerland?
Yes. Irinotecan-Teva liquid 40 mg/2 ml is authorised by Swissmedic under authorisation number 59217, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Irinotecan-Teva liquid 40 mg/2 ml have?
Irinotecan-Teva liquid 40 mg/2 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Irinotecan-Teva liquid 40 mg/2 ml?
The authorisation holder is Teva Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.